Learn how personalized cancer vaccines work and what to watch for at ESMO 2026. A vaccine made from a person’s own tumor has become the first of its kind to succeed in a phase 3 trial. Full results ...

What is an RNA vaccine? RNA vaccines, or messenger RNA (mRNA) vaccines, are a relatively new type of vaccine that delivers mRNA molecules to human cells, instructing them to produce specific antigens.

Vaccines are an important part of preventive care, yet many patients continue to have questions about how vaccines work, when they should be received, and what to expect during the vaccination process ...

COVID-19 vaccines lower the risk of getting sick, seriously ill or dying from the disease. But how do the different types of COVID-19 vaccines work? Each COVID-19 vaccine causes the immune system to ...

Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...

Professor Jeremy Sanford chairs the Department of Molecular, Cell, & Developmental Biology and co-directs the RNA Center at UC Santa Cruz. The U.S. Food and Drug Administration’s approval of the first ...

A vaccine combined with Keytruda is associated with a 49% reduction in the risk of recurrence or death. Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer ...

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, showing it a wanted poster for a single suspect. But what if one vaccine could ...

Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses, overturning a long-held assumption about how the vaccines work. The ...

Artificial intelligence isn't just being used to optimise productivity or complete the annoying tasks that we'd rather not do. Scientists have developed what they describe as the world's first ...

A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug ...